Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Clinical trial NCT03892096 · COMPLETED

Trial details

NCT number: NCT03892096
Sponsor: Cadex Genomics
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Non-Small Cell Lung Carcinoma Metastatic Colorectal Cancer Metastatic Breast Cancer

Start date: 2019-03-01
Primary completion: 2023-11-15
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.